Loss of MED23 leads to poor prognosis in invasive breast cancer
Purpose of the study: The molecular mechanism of lymphovascular invasion (LVI) which determines the early metastatic phenotype in breast cancer is still not fully understood. Lead from the METABRIC study revealed that MED23 correlated with negative LVI status (p=0.00005). Hence MED23 expression was...
| Main Authors: | , , , , , , , , , , |
|---|---|
| Format: | Conference or Workshop Item |
| Published: |
2017
|
| Online Access: | https://eprints.nottingham.ac.uk/44000/ |